These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8549309

  • 21. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN.
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract] [Full Text] [Related]

  • 22. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H, Kawazoe K, Izumi K, Ito K, Tamaya T.
    Drugs; 1995 Jul; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract] [Full Text] [Related]

  • 23. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S, Ajayi SO, Toki RA.
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [Abstract] [Full Text] [Related]

  • 24. Fluoronaphthyridines and -quinolones as antibacterial agents. 3. Synthesis and structure-activity relationships of new 1-(1,1-dimethyl-2-fluoroethyl), 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl], and 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituted derivatives.
    Remuzon P, Bouzard D, Cesare PD, Essiz M, Jacquet JP, Kiechel JR, Ledoussal B, Kessler RE, Fung-Tomc J.
    J Med Chem; 1991 Jan; 34(1):29-37. PubMed ID: 1992128
    [Abstract] [Full Text] [Related]

  • 25. Quinolones.
    Suh B, Lorber B.
    Med Clin North Am; 1995 Jul; 79(4):869-94. PubMed ID: 7791428
    [Abstract] [Full Text] [Related]

  • 26. 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationships.
    Frigola J, Parés J, Corbera J, Vañó D, Mercè R, Torrens A, Más J, Valentí E.
    J Med Chem; 1993 Apr 02; 36(7):801-10. PubMed ID: 8464033
    [Abstract] [Full Text] [Related]

  • 27. New quinolones--in vivo antibacterial activity.
    Goto S, Miyazaki S.
    Prog Drug Res; 1992 Apr 02; 38():29-37. PubMed ID: 1609116
    [No Abstract] [Full Text] [Related]

  • 28. Use of quinolones for the treatment of patients with bacteremia.
    Shah PM.
    Rev Infect Dis; 1989 Apr 02; 11 Suppl 5():S1156-9. PubMed ID: 2672247
    [Abstract] [Full Text] [Related]

  • 29. New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
    Sanchez JP, Bridges AJ, Bucsh R, Domagala JM, Gogliotti RD, Hagen SE, Heifetz CL, Joannides ET, Sesnie JC, Shapiro MA.
    J Med Chem; 1992 Jan 24; 35(2):361-7. PubMed ID: 1732554
    [Abstract] [Full Text] [Related]

  • 30. [New quinolones].
    Bello Dronda S.
    Arch Bronconeumol; 1999 May 24; 35 Suppl 3():70-6. PubMed ID: 10410229
    [No Abstract] [Full Text] [Related]

  • 31. From fluoroquinolones to 2-pyridones.
    Hooper DC.
    Lancet; 1995 May 13; 345(8959):1192-3. PubMed ID: 7739303
    [No Abstract] [Full Text] [Related]

  • 32. Epidemiology of quinolone resistance: Europe and North and South America.
    Goldstein FW, Acar JF.
    Drugs; 1995 May 13; 49 Suppl 2():36-42. PubMed ID: 8549361
    [Abstract] [Full Text] [Related]

  • 33. [New quinolones: similarities and differences].
    Levi GC.
    AMB Rev Assoc Med Bras; 1989 May 13; 35(5):202-6. PubMed ID: 2486418
    [Abstract] [Full Text] [Related]

  • 34. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K.
    Jpn J Antibiot; 1988 Nov 13; 41(11):1600-22. PubMed ID: 3210297
    [Abstract] [Full Text] [Related]

  • 35. [New antibacterial agents].
    Järvinen A, Valtonen V.
    Duodecim; 2000 Nov 13; 116(24):2803-5. PubMed ID: 12077883
    [No Abstract] [Full Text] [Related]

  • 36. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Wadworth AN, Goa KL.
    Drugs; 1991 Dec 13; 42(6):1018-60. PubMed ID: 1724637
    [Abstract] [Full Text] [Related]

  • 37. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
    Cutarelli PE, Lass JH, Lazarus HM, Putman SC, Jacobs MR.
    Curr Eye Res; 1991 Jun 13; 10(6):557-63. PubMed ID: 1893771
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of MF 5137, a new potent 6-aminoquinolone.
    Wise R, Pagella PG, Cecchetti V, Fravolini A, Tabarrini O.
    Drugs; 1995 Jun 13; 49 Suppl 2():272-3. PubMed ID: 8549329
    [No Abstract] [Full Text] [Related]

  • 39. The quinolones.
    Neu HC.
    Infect Dis Clin North Am; 1989 Sep 13; 3(3):625-39. PubMed ID: 2671143
    [Abstract] [Full Text] [Related]

  • 40. Effect of recent antibacterial agents against bacteria causing diarrhoea.
    Bergan T, Lolekha S, Cheong MK, Poh CL, Doencham S, Charoenpipop D.
    Scand J Infect Dis Suppl; 1988 Sep 13; 56():7-10. PubMed ID: 3266900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.